Management services organization for independent specialty physician practices
Revo Health runs back-office operations for independent specialty practices and surgery centers, spanning EHR (Epic, Allscripts), revenue cycle (Waystar), finance (NetSuite) and HR (UKG) systems. Hiring is accelerating and overwhelmingly clinical at mid and junior levels, pointing to frontline staffing for client clinics rather than corporate build-out. Recurring pain points around supply chain cost and inventory control show operating margin is a core lever.
Revo Health is a privately held management services organization headquartered in Minneapolis, Minnesota, founded in 2017. It handles business operations for independent specialty practices, including ASC development and management, revenue cycle, finance and accounting, HR, IT, compliance, risk management and supply chain. Clients span specialties such as cardiology, orthopedics, ophthalmology, pediatrics, women's health and ambulatory surgery centers. The company employs 201–500 people and hires within the United States.
Revo Health uses Epic, Allscripts, Waystar, NetSuite, UKG, Power BI, Tableau, SQL Server, PostgreSQL, Python, SSIS, HL7 FHIR, SysAid and Monday.com, among others.
Yes. Hiring is accelerating and concentrated in healthcare roles at mid and junior levels, with smaller openings in operations and finance, all in the United States.
Revo Health is a Minneapolis-based management services organization providing revenue cycle, finance, HR, IT, compliance, supply chain and ASC management to independent specialty practices.
Other companies in the same industry, closest in size
Revo Health's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.